Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Promising Breakthrough: Ketamine Therapy Offers New Hope for Mental Health Conditions and Chronic Pain

Honolulu, HI (Newsworthy.ai) Saturday Jan 20, 2024 @ 12:00 PM Eastern —

Ketamine, once used primarily for anesthesia purposes, has emerged as a potential game-changer in the treatment of major depression, PTSD, and suicidal ideation. The dissociative anesthetic drug, when administered in subanesthetic doses, disconnects individuals from troubling thoughts, memories, surroundings, actions, and identity. This unique effect has shown promising results in addressing a wide range of mental health issues, including depression, anxiety, PTSD, and chronic pain.

According to leading experts in the field, ketamine operates through multiple mechanisms to provide relief and support healing. By dissociating old neuronal connections, it paves the way for the formation of new, healthier connections. Additionally, ketamine boosts dopamine production while reducing brain swelling and inflammation.

The anti-reward center in the brain, known as the lateral habenula, plays a pivotal role in the efficacy of ketamine therapy. Trauma or ongoing disappointments can cause the lateral habenula to enter "burst mode," which results in depleted dopamine production and a profound sense of tiredness and lack of motivation. Ketamine effectively blocks this burst mode, rapidly restoring dopamine production and bringing relief and positive emotions to individuals.

While higher doses of ketamine have been known to cause hallucinations, particularly in patients with PTSD, the treatment remains safe and well-tolerated by the majority of patients. Common side effects include drowsiness, double vision, confusion, nausea, vomiting, dizziness, and feelings of unease.

Ketamine therapy is gaining recognition as a potential breakthrough in the treatment of mental health conditions and chronic pain. By targeting multiple mechanisms in the brain, this innovative approach offers renewed hope to individuals grappling with these challenges.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here Promising Breakthrough: Ketamine Therapy Offers New Hope for Mental Health Conditions and Chronic Pain.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.